What to Do After Getting Gut Microbiome Results

• Direct-to-consumer gut microbiome tests have documented analytical reproducibility problems; a 2025 study using an identical reference stool sample found results varied meaningfully between, and even within, testing companies.
• A 2024 international consensus of 69 experts across 18 countries concluded there is insufficient evidence to recommend routine use of microbiome testing in clinical practice.
• Most gut microbiome test findings describe associations at a population level; they haven't been shown to reliably predict an individual's disease risk or to justify one specific personalized diet.
• No U.S. regulator currently requires these tests to prove clinical validity before they're sold directly to consumers.
• The most evidence-based response to a result, good or concerning, is usually the same general pattern: more fiber diversity, more fermented foods, less ultra-processed food, not a bespoke plan built from the report.

Most consumer gut microbiome tests sequence DNA from a stool sample, either targeting one gene common to bacteria (16S rRNA sequencing, cheaper and lower-resolution) or sequencing a broader sample of all the DNA present (shotgun metagenomic sequencing, more detailed and more expensive). From that data, the test estimates which bacterial groups are present and in roughly what relative proportion, sometimes with predictions about metabolic functions the community might perform, such as fiber fermentation or vitamin production. Reports typically translate this into a "diversity score," a comparison against a reference population, and sometimes a proprietary "gut health" or "dysbiosis" score, along with food or supplement suggestions. It's worth knowing upfront that "dysbiosis" describes a microbial community that looks different from some reference average; it is not, by itself, a diagnosis of any specific disease.

Analytical validity asks a narrow question: does the test accurately and reproducibly measure what it claims to measure? A 2025 study submitted identical aliquots of a standardized reference stool sample, in triplicate, to seven direct-to-consumer testing companies. Results varied substantially both between companies and, in some cases, between three replicates sent to the same company; one company's functional-health scores flipped from above-average to below-average across replicates of the same material. The variability was attributed to differences in collection methods, sequencing depth, reference databases, and bioinformatics pipelines, and was on a similar scale to the natural biological variability between different people. If the same sample can produce different-looking results, a single test isn't a stable foundation for a health decision.

Clinical validity asks whether a result reliably corresponds to a defined health state, not just whether the measurement itself is reproducible. Here the evidence is thinner still. The 2024 international consensus statement, from a multidisciplinary panel of 69 experts, concluded that evidence linking most commercially reported microbiome metrics to individual disease states or health outcomes is currently insufficient to support their use as diagnostic or risk-prediction tools. Much of the underlying science comes from population-level associations, where certain bacterial patterns appear more often in people with a given condition, rather than evidence that one person's profile predicts their personal risk. Association isn't the same as a validated clinical marker, and the panel was explicit that the field isn't there yet.

Clinical utility asks the most practical question: does acting on a result actually improve outcomes, compared with not testing at all? No large randomized trial has shown that personalized diet or supplement recommendations generated from a commercial microbiome report produce better health outcomes than standard, evidence-based dietary advice, such as more fiber, more diverse plants, and less ultra-processed food. A 2025 legal analysis in the Journal of Law and the Biosciences concluded that direct-to-consumer marketing often overstates what these tests can do, creating a real risk that people spend money, and sometimes make health decisions, based on results that haven't been shown to change outcomes.

It can show, roughly, which bacterial groups were detected in that one sample and their relative abundance, a snapshot, not a stable trait; the microbiome shifts with diet, illness, travel, and medication within days. It cannot diagnose a disease, reliably predict your personal risk of one, or replace clinical stool testing your doctor might order for a specific concern, such as C. difficile, fecal calprotectin for inflammation, or occult blood. It cannot reliably tell you which specific foods will help you personally, despite what personalized recommendation engines imply, since that individual-level predictive step hasn't been validated. And a "low diversity" score doesn't say why; it could reflect low dietary fiber variety, recent antibiotics, illness, or ordinary person-to-person variation.

Before paying for a test, or acting heavily on one you already have, it's reasonable to ask: Is the lab CLIA-certified, and does that cover this specific assay (CLIA certifies lab process quality, not the clinical meaning of a result)? What sequencing method is used, and is the scoring methodology published in a peer-reviewed journal, not just described in marketing? Does the report disclose its own limitations? Is a clinician or dietitian involved in interpreting results, or is it fully automated? What happens to your data, and can you have it deleted? And concretely, what would change in your daily life for a "good" versus "concerning" score, given that no single recommendation has been shown in trials to beat general dietary guidance?

Resist the urge to overhaul your diet based on a single report. If a result flags something concerning, such as an unusual pathogen marker, don't self-treat; ask a clinician whether it warrants a validated clinical test. For the general "improve my gut health" goal most people are actually chasing, the evidence-based response is the same regardless of your specific report: build a wider variety of plant foods into your week, such as lentils, oats, and blueberry, add a fermented food like kimchi or sauerkraut most days, and include prebiotic-fiber vegetables like garlic and leek. Be skeptical of probiotic bundles marketed as "matched to your microbiome," since that matching claim is the part lacking trial support. If you retest later, keep the variability above in mind: a different score may reflect lab noise as much as anything you changed.

Bring the full report, not just the summary page, to your primary care provider or a gastroenterologist if you have ongoing symptoms. Most clinicians won't be able to interpret a company's proprietary diversity or dysbiosis score, since those scores aren't standardized or taught in clinical training, and that's a reasonable limitation for them to name rather than a gap in their expertise. More useful is describing the symptoms or goals that led you to test in the first place; a clinician can order validated clinical tests if something specific needs investigating, and a dietitian can help build a realistic, sustainable eating pattern. If the report suggested a supplement, ask whether it interacts with any medication you take before starting it.

A microbiome test result, reassuring or concerning, is not a substitute for medical evaluation of physical symptoms. See a clinician if you have blood in your stool, unintentional weight loss, persistent abdominal pain, a fever alongside digestive symptoms, or any new or worsening digestive symptoms, regardless of what your test report shows; a low-risk-looking report does not rule these out. If the report itself flags an unusual finding, such as a potential pathogen, do not attempt to self-treat with supplements, antibiotics, or an over-the-counter remedy; bring the report to a clinician who can order a validated diagnostic test to confirm or rule it out.

Commercial gut microbiome tests currently have real, documented problems with reproducibility (analytical validity) and with linking results to individual health outcomes (clinical validity and utility); a 2024 international expert consensus explicitly advised against relying on them for routine clinical decisions. Treat your results as a loose, one-time snapshot, not a diagnosis or a personalized prescription. The most defensible response to almost any result is the same general, well-evidenced pattern: more diverse fiber, more fermented foods, less ultra-processed food, discussed with a clinician if anything in the report raises a specific concern.

Should I buy a follow-up test to see if my diet change worked?

Be cautious. Since these tests show meaningful variation even on split samples from the same stool, a different score on a retest could reflect lab noise rather than a real change. If you do retest, use the same company and interpret small changes skeptically.

Are all gut microbiome tests equally unreliable?

The 2025 analytical study evaluated several major direct-to-consumer providers and found variability across all of them, though the degree differed by company and by which metric was being reported. None were shown to be consistently reliable enough for individual clinical decisions in that evaluation.

Can my doctor order a more reliable version of this test?

For specific clinical questions, such as suspected infection, inflammation, or bleeding, doctors order validated diagnostic stool tests, different from consumer microbiome panels, with established clinical validity for that question. There isn't yet a clinical-grade equivalent of the broad "whole microbiome" consumer report with proven individual predictive value.

Is it worth taking a probiotic the report recommended?

Probiotic effects are strain-specific and not interchangeable, and a report recommending a probiotic "based on your microbiome" is making a personalized-matching claim that hasn't been validated in trials. If you want to try a probiotic, look for one with trial evidence for your specific symptom, and expect to evaluate it directly rather than relying on the report's reasoning.

What should I do if the test found something I don't understand?

Don't try to self-diagnose from a glossary or company FAQ. Write down the specific finding and bring it to a clinician, who can tell you whether it's a normal variant, a lab artifact, or something that warrants a follow-up clinical test.

• International consensus statement on microbiome testing in clinical practice, The Lancet Gastroenterology & Hepatology (https://www.thelancet.com/journals/langas/article/PIIS2468-1253(24)00311-X/abstract)
• New international consensus on microbiome testing in clinical practice, Gut Microbiota for Health
• Evaluating the analytical performance of direct-to-consumer gut microbiome testing services, Communications Biology
• The DTC microbiome testing industry needs more regulation, Science
• Is the current regulatory framework for DTC microbiome-based tests sufficient to protect consumers, Journal of Law and the Biosciences, PMC
• Laboratory Developed Tests, U.S. Food and Drug Administration
• Food sources of dietary fiber, Dietary Guidelines for Americans